While DAT scans provide valuable insights into the state of the dopamine system, they are not definitive predictors of all toxicity outcomes. They can, however, help identify early changes in dopamine transporter availability before clinical symptoms become apparent. This early detection is crucial for implementing interventions that may mitigate further neurological damage.
